Marine Compounds and Cancer 2020

<p>The very first marine-derived anticancer drug Cytarabine (aka Ara-C Cytosar-U®) was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021 the list of approved marine-derived anticancer drugs consists of nine substances five of which received approval within the last two years demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field from agents with cancer-preventive activity to novel and previously characterized compounds with anticancer activity both in vitro and in vivo as well as the latest status of compounds under clinical development.</p>